Abstract
Background Aortic stiffness is closely linked with cardiovascular diseases, but recent studies suggest that it is also a risk factor for cognitive decline and dementia. However, the brain changes underlying this risk are unclear. We examined whether aortic stiffening in the transition from mid to late-life affects brain structure and cognition.
Methods and Findings Aortic pulse wave velocity was measured in 2007-09 (Phase 9) and at a 4-year follow-up in 2012-13 (Phase 11) in the Whitehall II Imaging Sub-study cohort. Between 2012-2016 (Imaging Phase), participants received a multi-modal 3T brain magnetic resonance imaging (MRI) scans and cognitive tests. Participants were selected if they had no clinical diagnosis of dementia and no gross brain structural abnormalities. Voxel-based analyses were used to assess grey matter volume, white matter microstructure (fractional anisotropy and diffusivity), cerebral blood flow, and white matter lesions. Cognitive outcomes were performance on verbal memory, semantic fluency, working memory and executive function tests. Of 544 participants, 445 (81.8%) were men. The mean (SD) age was 63.9 (5.2) years at the baseline Phase 9 examination, 67.9 (5.3) years at Phase 11 and 69.8 (5.2) years at the Imaging Phase. Voxel-based analysis revealed that accelerated aortic stiffening in mid-to-late life was associated with poor white matter integrity, viz. lower fractional anisotropy in 4.2% of white matter and higher radial diffusivity in 6.7% of white matter, including the corpus callosum, corona radiata, superior longitudinal fasciculus and corticospinal tracts. Accelerated aortic stiffening was also related to lower cerebral perfusion in 1.1% of grey matter including the parietal, frontal, and occipital cortices. No associations with grey matter volume or white matter lesions were observed. Further, higher baseline aortic stiffness was associated with poor semantic fluency (B=-0.48, 95%CI −0.77 to −0.19, p<0.005) and verbal learning outcomes (B=-0.36, 95%CI - 0.60 to −0.13, p<0.005).
Conclusions Faster aortic stiffening in mid-to-late life is associated with poor brain white matter microstructural integrity and reduced cerebral perfusion, likely due to increased transmission of pulsatile energy to the delicate cerebral microvasculature. Strategies to prevent arterial stiffening prior to this point may be required to offer cognitive benefit in older age.
Competing Interest Statement
Professor John E Deanfield reports provision of medical consulting for the Brain Protection Company Ltd. The remaining authors declare no conflicts of interest.
Clinical Trial
NCT03335696
Funding Statement
The Whitehall II study is supported by the British Heart Foundation (RG/16/11/32334), UK Medical Research Council (K013351) and US National Institute on Aging (R01AG013196; R01AG034454; R01AG056477). The Whitehall II Imaging Sub-study was supported by the UK Medical Research Council (MRC) grants (Predicting MRI abnormalities with longitudinal data of the Whitehall II Sub-study) (G1001354; PI KPE; ClinicalTrials.gov Identifier: NCT03335696), and (Adult Determinants of Late Life Depression, Cognitive Decline and Physical Functioning - The Whitehall II Ageing Study) (MR/K013351/1; PI: MK). Working on this study was also supported by European Commission (Horizon 2020 grant Lifebrain, 732592; co-PI KPE), the HDH Wills 1965 Charitable Trust (1117747; PI KPE) and the UK National Institute of Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC). The Wellcome Centre for Integrative Neuroimaging (WIN) is supported by core funding from the Wellcome Trust (203139/Z/16/Z). The authors report the following funding: SS (Alzheimers Society Research Fellowship (Grant Number 441)), KPE (UK Medical Research Council (G1001354, MR/K013351/), HDH Wills 1965 Charitable Trust (1117747), Alzheimer Research UK (PPG2012A-5) and the European Commission (Horizon 2020 grant Lifebrain, 732592)), MK (UK MRC (MR/K013351/1, MR/R024227/1, MR/S011676/1), National Institute on Aging (NIH), US (R01AG056477), NordForsk (75021), Academy of Finland (311492), Helsinki Institute of Life Science Fellowship (H970)), LG (Monument Trust Discovery Award from Parkinsons UK (J-1403) and the MRC Dementias Platform UK (MR/L023784/2)), ASM (NIH (R01AG056477, R01AG062553)). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Oxford Medical Sciences Interdivisional Research Ethics Committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study follows Medical Research Council data sharing policies (https://mrc.ukri.org/research/policies-and-guidance-for-researchers/data-sharing/). In accordance with these guidelines, data from the Whitehall II Imaging Sub-study will be accessible via the Dementias Platform UK (https://portal.dementiasplatform.uk/). Data from the Whitehall II Study is available through formal request to the data sharing committee (https://www.ucl.ac.uk/iehc/research/epidemiology-public-health/research/whitehallII/data-sharing).
https://portal.dementiasplatform.uk/
https://www.ucl.ac.uk/iehc/research/epidemiology-public-health/research/whitehallII/data-sharing
